Price History
Feb 9, 2026 — Apr 4, 2026Investment Snapshot
- Trading 55% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 5/9 — moderate financial health
- ROE of 5.3% — below-average profitability
- Revenue declining 13% annually
Synergy CHC Corp. - Common Stock (SNYR) is a Healthcare company operating in Medical Distribution, listed on the NASDAQ , with a market capitalisation of $15 million . Key value metrics: P/E ratio 4.5, Piotroski F-Score 5 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Synergy CHC Corp. - Common Stock — Fundamental Analysis Summary
Synergy CHC Corp. - Common Stock (SNYR) is currently trading 55% above its Graham Number of $0.83, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries a low trailing P/E ratio of 4.5x.
On financial health, SNYR shows a moderate Piotroski F-Score of 5/9, and modest return on equity of 5.3% (sector average: -19.8%).
StockPik's composite Value Score for SNYR is 82/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
SNYR reports a high gross margin of 72.7% (sector average: 33.5%) and a solid operating margin of 18.8%.
SNYR shows revenue declining at 13% year-over-year, with earnings declining at 681%.